Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beth D Darnall

Showing results (31-40 of 165) with videos related to

Pageof 17
Sort By:
Pain Medicine (Malden, Mass.)|November 8, 2014
Urine drug screening: necessary or alienating?Beth D Darnall, Michael E Schatman
Pain Medicine (Malden, Mass.)|November 8, 2014
Urine drug screening: opioid risks preclude complete patient autonomyBeth D Darnall, Michael E Schatman
Pain Medicine (Malden, Mass.)|November 19, 2013
Among disparate views, scales tipped by the ethics of system integrityMichael E Schatman, Beth D Darnall
Pain Medicine (Malden, Mass.)|November 19, 2013
Upscheduling of hydrocodone: convenience and access vs patient safety measuresMichael E Schatman, Beth D Darnall
Journal of Pain Research|December 20, 2013
A practical and ethical solution to the opioid scheduling conundrumMichael E Schatman, Beth D Darnall
Pain Medicine (Malden, Mass.)|June 22, 2013
Ethical pain care in a complex caseMichael E Schatman, Beth D Darnall
Addiction (Abingdon, England)|June 9, 2018
An experimental method for assessing whether marijuana use reduces opioid use in patients with chronic painBeth D Darnall, Keith N Humphreys
Brain, Behavior, and Immunity|March 11, 2009
Sex and gender in psychoneuroimmunology research: past, present and futureBeth D Darnall, Edward C Suarez
Pain|August 12, 2021
Clinical and neuroscience evidence supports the critical importance of patient expectations and agency in opioid taperingBeth D Darnall, Howard L Fields
Gender Medicine|July 20, 2010
Pilot study of inflammatory responses following a negative imaginal focus in persons with chronic pain: analysis by sex/genderBeth D Darnall, Mikel Aickin, Heather Zwickey
Pageof 17

Showing results (31-40 of 165) with videos related to

Sort By:
Pageof 17
Pain Medicine (Malden, Mass.)|November 8, 2014
Urine drug screening: necessary or alienating?Beth D Darnall, Michael E Schatman
Pain Medicine (Malden, Mass.)|November 8, 2014
Urine drug screening: opioid risks preclude complete patient autonomyBeth D Darnall, Michael E Schatman
Pain Medicine (Malden, Mass.)|November 19, 2013
Among disparate views, scales tipped by the ethics of system integrityMichael E Schatman, Beth D Darnall
Pain Medicine (Malden, Mass.)|November 19, 2013
Upscheduling of hydrocodone: convenience and access vs patient safety measuresMichael E Schatman, Beth D Darnall
Journal of Pain Research|December 20, 2013
A practical and ethical solution to the opioid scheduling conundrumMichael E Schatman, Beth D Darnall
Pain Medicine (Malden, Mass.)|June 22, 2013
Ethical pain care in a complex caseMichael E Schatman, Beth D Darnall
Addiction (Abingdon, England)|June 9, 2018
An experimental method for assessing whether marijuana use reduces opioid use in patients with chronic painBeth D Darnall, Keith N Humphreys
Brain, Behavior, and Immunity|March 11, 2009
Sex and gender in psychoneuroimmunology research: past, present and futureBeth D Darnall, Edward C Suarez
Pain|August 12, 2021
Clinical and neuroscience evidence supports the critical importance of patient expectations and agency in opioid taperingBeth D Darnall, Howard L Fields
Gender Medicine|July 20, 2010
Pilot study of inflammatory responses following a negative imaginal focus in persons with chronic pain: analysis by sex/genderBeth D Darnall, Mikel Aickin, Heather Zwickey
Pageof 17